Ukko Company
We are building a comprehensive, clinically validated map of the molecular structure of food allergies and disorders, unlocking critical knowledge about the biological mechanisms that drive human food interactions.
On the basis of this map, we design proteins that do not trigger an immune response. These proteins are then applied to the food and therapeutics markets.
Headquarters:
Palo Alto, California, United States
Investors Number:
8
Last Funding Type:
Series B
Last Funding Date:
27.01.2021
Funding Status:
Early Stage Venture
Employee Number:
1-10
Founded Date:
01.01.2016
Industry:
FoodScience
Total Funding:
47699997
Technology:
Others